Squarepoint Ops LLC Kura Oncology, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$17.53 - $22.98 $1.38 Million - $1.81 Million	-78,969 Reduced 82.87%	16,319 $336,000
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $1,731 - $3,035	129 Added 0.14%	95,288 $2.03 Million
Q4 2023 Feb 14, 2024	BUY	$7.58 - $14.38 $398,101 - $755,237	52,520 Added 123.17%	95,159 $1.37 Million
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $246,416 - $358,353	25,615 Added 150.46%	42,639 $451,000
Q1 2023 May 15, 2023	SELL	$10.71 - $14.6 $418,771 - $570,874	-39,101 Reduced 69.67%	17,024 $208,000
Q4 2022 Feb 14, 2023	SELL	$11.23 - $16.9 $238,907 - $359,530	-21,274 Reduced 27.49%	56,125 $696,000
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $523,419 - $847,669	43,582 Added 128.88%	77,399 $1.06 Million
Q2 2022 Aug 15, 2022	BUY	$10.71 - $18.33 $362,180 - $619,865	33,817 New	33,817 $620,000
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $472,601 - $681,220	-40,119 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $490,254 - $785,128	40,119 New	40,119 $562,000
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $606,160 - $853,813	-39,310 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$20.85 - $29.88 $127,581 - $182,835	-6,119 Reduced 13.47%	39,310 $820,000
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $242,401 - $383,337	9,794 Added 27.48%	45,429 $1.28 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $386,947 - $555,335	13,343 Added 59.86%	35,635 $1.16 Million
Q3 2020 Nov 16, 2020	SELL	$16.3 - $30.64 $500,915 - $941,597	-30,731 Reduced 57.96%	22,292 $683,000
Q2 2020 Aug 14, 2020	SELL	$7.95 - $18.81 $306,615 - $725,464	-38,568 Reduced 42.11%	53,023 $864,000
Q1 2020 May 15, 2020	SELL	$6.45 - $14.04 $242,816 - $528,549	-37,646 Reduced 29.13%	91,591 $911,000
Q4 2019 Feb 14, 2020	BUY	$12.97 - $15.94 $608,007 - $747,235	46,878 Added 56.92%	129,237 $1.78 Million
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $849,821 - $1.2 Million	57,615 Added 232.84%	82,359 $1.25 Million
Q2 2019 Aug 14, 2019	BUY	$14.71 - $19.79 $209,588 - $281,967	14,248 Added 135.75%	24,744 $487,000
Q1 2019 May 15, 2019	SELL	$13.73 - $16.87 $608,239 - $747,341	-44,300 Reduced 80.85%	10,496 $174,000
Q4 2018 Feb 14, 2019	SELL	$10.6 - $17.49 $96,714 - $159,578	-9,124 Reduced 14.27%	54,796 $769,000
Q3 2018 Nov 14, 2018	BUY	$16.65 - $21.85 $491,507 - $645,012	29,520 Added 85.81%	63,920 $1.12 Million
Q2 2018 Aug 14, 2018	BUY	$14.8 - $18.8 $247,500 - $314,392	16,723 Added 94.6%	34,400 $626,000
Q1 2018 May 15, 2018	BUY	$14.5 - $23.4 $89,885 - $145,056	6,199 Added 54.01%	17,677 $331,000
Q4 2017 Feb 14, 2018	BUY	$13.5 - $16.65 $154,953 - $191,108	11,478	11,478 $176,000

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

Suvretta Capital Management, LLC New York, NY

7.65M
Shares

$69 Million
5.88% of portfolio
Black Rock Inc. New York, NY

6.97M
Shares

$62.8 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.81M
Shares

$52.3 Million
4.92% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

5.41M
Shares

$48.8 Million
1.97% of portfolio
Paradigm Biocapital Advisors LP New York, NY

4.33M
Shares

$39 Million
3.05% of portfolio

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account